GLP-1 wars: Lilly's FDA-approved oral weight-loss pill puts Novo Nordisk's Wegovy franchise under fresh pressure

Foundayo launches on April 6 at the same price as Novo's pill, threatening to reshape the $50 billion obesity drug market ...
Courthouse News Service

Abortion pill reversal providers challenge California over commercial speech at Ninth Circuit

Culture of Life Services attorney Peter Breen argues before a three-judge panel at the Ninth Circuit Court of Appeals on Thursday, Oct. 9, in Pasadena, Calif. (Ninth Circuit Court of Appeals image via ...
Healthline

Everything You Want to Know About the New GLP-1 Pill

On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide). The GLP-1 pill is still prescription-only, but ...
NPR

5 things to know about the new obesity pill

Millions of people use injectable drugs like Wegovy to reach a healthier weight. But the weekly injections aren't for everybody — or every wallet. That's why pills that could achieve similar results ...